Nagaileben Co., Ltd.
Stock Price Chart
2026/08/21 UpdatedPrice Trend
2026/08/21 UpdatedPrice & Trading Details
2026/08/21 UpdatedPRICE
TRADING
Shareholder Composition
Updated 2026/08/01Dividend History 1Years Growth
Updated 2026/08/23| Year | Dividend | Change |
|---|---|---|
| 2025 | ¥100 | +66.7% |
| 2024 | ¥60 | 0.0% |
| 2023 | ¥60 | 0.0% |
| 2022 | ¥60 | 0.0% |
| 2021 | ¥60 | - |
Financial Performance
2026/08/23 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥17,745M | ¥17,182M | ¥16,413M | ¥16,984M |
| Gross Profit | ¥7,882M | ¥7,547M | ¥7,029M | ¥6,712M |
| Operating Income | ¥5,032M | ¥4,605M | ¥4,005M | ¥3,583M |
| Pretax Income | ¥5,032M | ¥4,605M | ¥4,005M | ¥3,583M |
| Net Income | ¥3,778M | ¥3,226M | ¥2,822M | ¥2,573M |
| EPS | ¥115.77 | ¥100.04 | ¥88.77 | ¥83.24 |
| Operating Margin | 28.35% | 26.80% | 24.40% | 21.10% |
| Balance Sheet | ||||
| Total Assets | ¥47,348M | ¥47,378M | ¥46,727M | ¥44,692M |
| Total Equity | ¥42,255M | ¥43,214M | ¥42,697M | ¥41,318M |
| Total Liabilities | ¥5,093M | ¥4,164M | ¥4,030M | ¥3,374M |
| Cash | ¥28,561M | ¥27,159M | ¥26,349M | ¥24,246M |
| Interest-bearing Debt | - | - | - | - |
| Equity Ratio | 89.24% | 91.21% | 91.38% | 92.45% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow | ||||
| Operating CF | ¥3,443M | ¥1,813M | ¥2,287M | ¥2,181M |
| Investing CF | -¥471M | ¥3,418M | -¥1,769M | ¥1,110M |
| Financing CF | -¥3,203M | -¥2,935M | -¥2,930M | -¥3,894M |
| Free CF | ¥3,327M | ¥1,528M | ¥2,119M | ¥1,792M |
| Efficiency | ||||
| ROE | 8.94% | 7.47% | 6.61% | 6.23% |
| ROA | 7.98% | 6.81% | 6.04% | 5.76% |
Latest IR Information
-
Notice Regarding Share Buyback Status and Completion
The acquired shares consist of 157,900 common shares, total amount 279,133,900 yen, the period from August 1, 2026 to August 12, acquired through market purchases, with completion disclosed as well
Read more -
Notice Regarding Share Buyback Status
The acquired shares are common shares totaling 360,400 shares with total acquisition value of 6,382,784,00 yen. The period is 2026/7/1 to 2026/7/31 (on a responsive basis), and the method is market purchases. For reference, at the June 29 resolution, the...
Read more -
[Nagai Leiben] Introduction of Executive Officer System and Change in Management Structure | November 2026
Nagai Leiben will introduce an executive officer system on September 1, 2026, to revamp its management structure. The number of directors will be reduced to 6, with 2 independent outside directors planned to be appointed.
Read more -
Notice Regarding Share Buyback Status
Based on the board meeting resolution as of June 29, 2026, ordinary shares are being acquired by market purchases during the ongoing acquisition period. As of the interim period ending June 30, 2026, the number of shares acquired is 46,700,...
Read more
Latest News (5 items)
Company Information
About
Nagaileben Co., Ltd. manufactures and sells medical clothing in Japan. The company engages in sale, import, and export of various white clothing and hospital shoes and socks. It also offers hospital, clinic, surgical, and nursing facility clothing products, as well as surgical linen. The company was founded in 1915 and is headquartered in Tokyo, Japan.
